Oct 2010 | Missouri

Remedies (MO) acquired by Remedies Inc. (NY)

Generational Equity, a leading advisor to privately held and family-owned businesses for mergers, acquisitions, strategic growth initiatives, business valuation and exit planning announced the acquisition of its client, B-Pharm, Inc. dba Remedies Pharmacy, headquartered in Carrollton, Missouri, by a private investment group. The transaction closed on October 26, 2010.

Managing Director, Terry Mackin and Assistant Vice President, Kyle Coe, led the Generational Equity deal team that advised B-Pharm, Inc. "Our client had an immediate need to exit the business for family reasons, but wanted to find a buyer willing to purchase the company along with the real estate, and would want to keep the same community-minded approach in place that the sellers had so successfully instilled in the business and their employees," said Terry Mackin. "The buyers recognized right away the value in purchasing the entire entity and using the goodwill of employee loyalty and a locally trusted name as a platform for continued growth." B-Pharm dba Remedies Pharmacy is a pharmacy and full-line durable medical equipment (DME) business. The Company is a one-stop shop, including a health care product mix that is augmented with traffic-generating products and services such as over-the-counter (OTC) medicines and gifts. It is also an official United States Postal Contract Station and a UPS shipping station, which has proven to be a value-added service for its mail order respiratory medications and diabetic supply divisions. The company was purchased by Remedies Inc., a private investment group in New York.


If you would like to explore other transactions our associates have supported in this industry, visit our dedicated Healthcare & Life Sciences page.

If you would like to explore other transactions our associates have supported in this industry, visit our dedicated Retail page.

View Press Release


Generational can help business owners, buyers and investors to make the most of M&A opportunities during 2024. Find an Executive Conference near you or get in contact with our expert advisors today.